1-4 of 4
telmisartan
Close
Sort by
Journal Articles

Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim Analysis

Sujatha Iyengar, PhD, Scott D. Rowley, MD, Caixin Zhan, Michele L. Donato, MD, Themba Nyirenda, PhD, David H. Schwartz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4546.
https://doi.org/10.1182/blood-2019-129378
Published: 2019
Journal Articles

High Dose Telmisartan for Prevention of Acute Graft Vs. Host Disease

David H. Schwartz, MD/ PhD, Sujatha Iyengar, PhD, Michele L Donato, MD FACP, Alan P Skarbnik, MD, David H. Vesole, MD, Scott D. Rowley, MD FACP, Themba L Nyirenda, PhD
Journal: Blood
Blood (2016) 128 (22): 5783.
https://doi.org/10.1182/blood.V128.22.5783.5783
Published: 2016
Journal Articles

Telmisartan, Angiotensin II Receptor Blocker, Induces Apoptosis and Autophagy in Adult T-Cell Leukemia Cells from Patients and Leukemia Cell Lines

Tomohiro Kozako, PhD, Makoto Yoshimitsu, MD PhD, Naomichi Arima, MD PhD, Shuhei Soeda, PhD, Shinya Hirata, MD PhD, Hiroaki Tanaka, PhD, Shin-ichiro Honda, PhD, Shinji Soeda, PhD
Journal: Blood
Blood (2015) 126 (23): 2055.
https://doi.org/10.1182/blood.V126.23.2055.2055
Published: 2015
Journal Articles

Inhibition of angiotensin I–converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells

Sabine Charrier, Annie Michaud, Sabrina Badaoui, Sébastien Giroux, Eric Ezan, Françoise Sainteny, Pierre Corvol, William Vainchenker
Journal: Blood
Blood (2004) 104 (4): 978–985.
https://doi.org/10.1182/blood-2003-11-3828
Published: 2004